New York Times, February 7, 2019
Gina Kolata


Read the Full Article

[...] The device works in rats and pigs, the investigators reported on Thursday in the journal Science. The researchers — at M.I.T., Harvard and Novo Nordisk, the pharmaceutical company — hope to start testing Soma in humans in three years.

Outside experts said the device may well be a viable solution to the injection problem. “It’s a very new concept and a really cool idea,” said Edith Mathiowitz, a professor of medical science and engineering at Brown University. [...]

biotechnology pharmaceuticals